Oncocyte: Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ:OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham Virtual Healthcare Conference, taking place from April 7-10, 2025. In addition, CEO Josh Riggs will participate in a fireside chat at the conference.During the event, Josh and Andrea will discuss Oncocyte's innovative diagnostic technologies and will highlight the company's progress toward commercializing a regulated organ transplant rejection monitoring test kit. The company is pursuing a market-disruptive approach, positioning Oncocyte to lead the way in advancing transplant monitoring solutions.Investors wishing to attend the virtual fireside chat or schedule one-on-one meetings are encouraged to reach out to their Needham sales representative to express interest.Event: 24th Annual Needham Virtual Healthcare ConferenceDates: April 7-10, 2025Oncocyte Fireside Chat: April 7, 2025, 3:45 PM (ET)Location: VirtualFor more information about Oncocyte and its products, please visit www.oncocyte.com.About OncocyteOncocyte is a diagnostics technology company. The Company's tests are designed to help provide clarity and confidence to physicians and their patients. VitaGraft is a clinical blood-based solid organ transplantation ...Full story available on Benzinga.com